lorazepam has been researched along with Brain Disorders in 7 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Risk factors for the disease include older age, renal dysfunction, critical illness, and inappropriate dosing based upon renal function." | 5.56 | Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert. ( Allyn, R; Cunningham, JM; Sachs, KV, 2020) |
| "Lorazepam was initiated but did not control the catatonic symptoms." | 3.01 | Catatonia as the Presentation of Encephalopathy Associated With Autoimmune Thyroiditis: A Case Report and Literature Review. ( Al-Ghannami, AK; Ali, HT; Caprara, ALF; Mohamed, FR; Rissardo, JP, 2023) |
| "Minimal requirements: seizure-prevention outcome given as fraction of cases; AED or control assigned by random or quasi-random mechanism." | 2.41 | Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. ( Temkin, NR, 2001) |
| " Risk factors for the disease include older age, renal dysfunction, critical illness, and inappropriate dosing based upon renal function." | 1.56 | Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert. ( Allyn, R; Cunningham, JM; Sachs, KV, 2020) |
| "Subacute encephalopathy with seizures in chronic alcoholism (SESA) was first described in 1981 by Niedermeyer who reported alcoholic patients presenting with confusion, seizures and focal neurological deficits and is quite distinct from patients presenting with typical alcohol withdrawal seizures." | 1.37 | Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus. ( LaRoche, SM; Shivdat-Nanhoe, R, 2011) |
| "Psychosis and auditory hallucinations are characteristic features of schizophrenia, but may also complicate many somatic diseases." | 1.34 | A vanishing lesion in the temporal lobe associated with schizophrenialike psychosis and catatonia. ( Beerepoot, LJ; Kho, KH; Sommer, IE; van Veelen, NM, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, HT | 1 |
| Mohamed, FR | 1 |
| Al-Ghannami, AK | 1 |
| Caprara, ALF | 1 |
| Rissardo, JP | 1 |
| Cunningham, JM | 1 |
| Sachs, KV | 1 |
| Allyn, R | 1 |
| LaRoche, SM | 1 |
| Shivdat-Nanhoe, R | 1 |
| Hunt, CH | 1 |
| Wood, CP | 1 |
| Lane, JI | 1 |
| Bolster, BD | 1 |
| Bernstein, MA | 1 |
| Witte, RJ | 1 |
| Wehrschuetz, M | 1 |
| Simbrunner, J | 1 |
| Enzinger, C | 1 |
| Ebner, F | 1 |
| Kho, KH | 1 |
| van Veelen, NM | 1 |
| Beerepoot, LJ | 1 |
| Sommer, IE | 1 |
| Temkin, NR | 1 |
2 reviews available for lorazepam and Brain Disorders
| Article | Year |
|---|---|
Catatonia as the Presentation of Encephalopathy Associated With Autoimmune Thyroiditis: A Case Report and Literature Review.
Topics: Brain Diseases; Catatonia; Female; Hashimoto Disease; Humans; Lorazepam; Middle Aged; Thyroiditis, A | 2023 |
Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials.
Topics: Anticonvulsants; Brain Diseases; Brain Injuries; Carbamazepine; Controlled Clinical Trials as Topic; | 2001 |
5 other studies available for lorazepam and Brain Disorders
| Article | Year |
|---|---|
Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Anticonvulsants; Aphasia; Brain Diseases; Cefepime | 2020 |
Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus.
Topics: Acetamides; Alcohol Withdrawal Seizures; Alcoholism; Anticonvulsants; Brain Diseases; Confusion; Dif | 2011 |
Wide, short bore magnetic resonance at 1.5 t: reducing the failure rate in claustrophobic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia, General; Brain Diseases; Child; Equipment De | 2011 |
[Hemiballism-hemichorea syndrome].
Topics: Anti-Dyskinesia Agents; Brain Diseases; Cerebrovascular Circulation; Chorea; Drug Therapy, Combinati | 2007 |
A vanishing lesion in the temporal lobe associated with schizophrenialike psychosis and catatonia.
Topics: Adult; Aggression; Antipsychotic Agents; Brain Diseases; Catatonia; Delusions; Diffusion Magnetic Re | 2007 |